Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Corticosteroids in Young Children with Episodic Wheezing
2025-522694-11-00Phase 4Authorised
- Sponsor
- Erasmus MC
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of beclomethasone, budesonide and fluticasone in Wheezing disorder (2 arms), sponsored by Erasmus MC. Primary endpoint: Symptom control. Planned start Oct 2025; status: authorised.
02
Drugs
beclomethasonebudesonidefluticasone
03
Conditions
Wheezing disorder
Beyond the preview
Go deeper on 2025-522694-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522694-11-00.